FSCN1 and breast cancer: The fact that this phenomenon was observed in hormone receptor–negative basal-like (MDA-MB-231) and hormone receptor–positive luminal (T-47D) breast cancer cells strongly suggests that fascin/FAK activates β-catenin signaling pathway regardless of the hormone receptor status or breast cancer subtypes.